Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Autophagic Cell Death01:18

Autophagic Cell Death

3.6K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.6K
Apoptosis01:30

Apoptosis

12.2K
Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
12.2K
Overview of Cell Death01:30

Overview of Cell Death

8.0K
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
8.0K
Necrosis01:16

Necrosis

5.0K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
5.0K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

7.0K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
7.0K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

15.3K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
15.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Programmed axon degeneration: mechanism, inhibition and therapeutic potential.

Nature reviews. Neuroscience·2025
Same author

Targeting SARM1: from inhibition for neuroprotection to activation for neuroablation.

Trends in pharmacological sciences·2025
Same author

SARM1 activation induces reversible mitochondrial dysfunction and can be prevented in human neurons by antisense oligonucleotides.

Neurobiology of disease·2025
Same author

Advancing neuroprotection in glaucoma and AMD - a new horizon?

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie·2025
Same author

Chronically Low NMNAT2 Expression Causes Sub-lethal SARM1 Activation and Altered Response to Nicotinamide Riboside in Axons.

Molecular neurobiology·2024
Same author

Author Correction: NMNAT2 is a druggable target to drive neuronal NAD production.

Nature communications·2024
Same journal

Building neuroscience capacity in low- and middle-income countries: Lessons from Ghana.

Trends in neurosciences·2026
Same journal

Emulating the periodic table: A unified list of CNS terms and abbreviations for humans and experimental animals.

Trends in neurosciences·2026
Same journal

From chromatin dynamics to brain disease: Polycomb-Trithorax mechanisms in neurodevelopment.

Trends in neurosciences·2026
Same journal

Striatum regulates the cortex via the basal forebrain cholinergic system: A role for substance P.

Trends in neurosciences·2026
Same journal

A large brain adds new types of neurons: Molecular and functional signatures of spindle neurons in the human neocortex.

Trends in neurosciences·2026
Same journal

Exercise as a regulator of glymphatic function.

Trends in neurosciences·2026
See all related articles

Related Experiment Video

Updated: Oct 11, 2025

Morphological and Functional Evaluation of Axons and their Synapses during Axon Death in Drosophila melanogaster
10:29

Morphological and Functional Evaluation of Axons and their Synapses during Axon Death in Drosophila melanogaster

Published on: March 16, 2020

8.1K

Mitochondrial dysfunction as a trigger of programmed axon death.

Elisa Merlini1, Michael P Coleman1, Andrea Loreto1

  • 1John van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Forvie Site, Cambridge CB2 0PY, UK.

Trends in Neurosciences
|December 2, 2021
PubMed
Summary
This summary is machine-generated.

Mitochondrial dysfunction can trigger programmed axon death (Wallerian degeneration) even without injury. This discovery highlights potential new drug targets to protect axons in neurodegenerative diseases.

Keywords:
Parkinson’s diseaseSARM1Wallerian degenerationaxon degenerationmitochondrial dysfunctionprogrammed axon death

More Related Videos

Microfluidics-Assisted Selective Depolarization of Axonal Mitochondria
06:55

Microfluidics-Assisted Selective Depolarization of Axonal Mitochondria

Published on: August 4, 2022

2.0K
Three-dimensional Imaging and Analysis of Mitochondria within Human Intraepidermal Nerve Fibers
10:31

Three-dimensional Imaging and Analysis of Mitochondria within Human Intraepidermal Nerve Fibers

Published on: September 29, 2017

10.4K

Related Experiment Videos

Last Updated: Oct 11, 2025

Morphological and Functional Evaluation of Axons and their Synapses during Axon Death in Drosophila melanogaster
10:29

Morphological and Functional Evaluation of Axons and their Synapses during Axon Death in Drosophila melanogaster

Published on: March 16, 2020

8.1K
Microfluidics-Assisted Selective Depolarization of Axonal Mitochondria
06:55

Microfluidics-Assisted Selective Depolarization of Axonal Mitochondria

Published on: August 4, 2022

2.0K
Three-dimensional Imaging and Analysis of Mitochondria within Human Intraepidermal Nerve Fibers
10:31

Three-dimensional Imaging and Analysis of Mitochondria within Human Intraepidermal Nerve Fibers

Published on: September 29, 2017

10.4K

Area of Science:

  • Neuroscience
  • Cell Biology
  • Biochemistry

Background:

  • Programmed axon death, or Wallerian degeneration (WD), is a key process in axon degeneration.
  • Mitochondria have been implicated in the execution phase of WD in injured axons.
  • Emerging evidence suggests mitochondrial dysfunction can initiate WD independently of physical injury.

Purpose of the Study:

  • To review recent findings linking mitochondrial dysfunction to programmed axon death.
  • To discuss the implications of these findings for axon injury and neurodegenerative diseases.
  • To explore potential therapeutic strategies targeting mitochondrial pathways.

Main Methods:

  • Literature review of recent studies on mitochondrial dysfunction and axon degeneration.
  • Analysis of mechanisms by which mitochondrial impairment initiates programmed axon death.
  • Discussion of the role of mitochondrial dysfunction in diseases characterized by axon loss.

Main Results:

  • Mitochondrial dysfunction is increasingly recognized as an initiator of programmed axon death, not just a participant in the execution phase.
  • This process can occur even in the absence of physical axonal injury.
  • Disruptions in mitochondrial function are linked to axon loss in conditions like Parkinson's disease, peripheral neuropathies, and multiple sclerosis.

Conclusions:

  • Mitochondrial dysfunction is a critical factor in initiating programmed axon death.
  • Understanding this link offers opportunities for developing novel therapeutic interventions.
  • Targeting druggable mitochondrial mechanisms may protect axons in various neurological disorders.